The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers

Overview of attention for article published in Frontiers in immunology, August 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 1 X post from an account with 33,399 followers.

New Research: The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers: Background we evaluated the concordance between immunohistochemical p53 staining and TP53 mutations in a series of HGSOC.… #immunology https:

23 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.